Skip to main content
Log in

Is there a gender-related susceptibility for cisplatin ototoxicity?

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Ototoxicity is a well-known side effect of cisplatin. Some genetic and non-genetic risk factors were described for cisplatin ototoxicity. Although there are some studies which point out a sex-related difference for cisplatin nephrotoxicity and neurotoxicity, sex-related differences for cisplatin ototoxicity have not been studied. The aim of this study is to reveal whether there is any gender-related difference for susceptibility to cisplatin ototoxicity in rats. Fourteen male, 14 female Wistar albino rats were divided into four groups; a female control, a male control, a female cisplatin and a male cisplatin group. Distortion Product Otoacoustic Emission and, Auditory Brainstem Response measurements were obtained. For the cisplatin groups 16 mg/kg of cisplatin was applied. On the 4th day audiological examinations were repeated. After killing, cochleae and brainstem tissues were evaluated by light and electron microscopy. The hearing of the female rat cisplatin group was found to have deteriorated more than the hearing of the male rat cisplatin group. Histopathological evaluation revealed more serious damage in the spiral ganglion and brainstem tissues of female rats. Hearing of female rats deteriorated more than the hearing of male rats upon application of cisplatin. This difference in hearing can be attributed to the more severe damage seen in neuronal tissues such as spiral ganglion cells and brainstem neurons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Wongtawatchai T, Agthong S, Kaewsema A, Chentanez V (2009) Sex related differences in cisplatin- induced neuropathy in rats. J Med Assoc Thai 92:1485–1491

    PubMed  Google Scholar 

  2. Aydın I, Agilli M (2014) Aydin FN gender differences influences renal injury in cisplatin- treated rats: biochemical evaluation. Biol Trace Elem Res 158:275. doi:10.1007/S12011-014-9945-3

    Article  PubMed  Google Scholar 

  3. Jazi FE, Nematbakhsh M, Pezeshkin Z et al (2013) Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats. Iran J Kidney Dis 7:383–389

    Google Scholar 

  4. Olgun Y, Kırkım G, Kolatan E et al (2014) Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity. Laryngoscope 124:760–766

    Article  CAS  PubMed  Google Scholar 

  5. Güneş D, Kırkım G, Kolatan E et al (2011) Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity. Chemotherapy 57(3):186–194

    Article  PubMed  Google Scholar 

  6. Olgun Y, Kırkım G, Kolatan E (2013) Otoprotective effect of recombinant human erythropoietin in a model of newborn hypoxic-ischemic encephalopathy. Int J Pediatr Otorhinolaryngol 77:739–746

    Article  PubMed  Google Scholar 

  7. Nicolson TJ, Mellor HR, Roberts RR (2010) Gender differences in drug toxicity. Trends Pharmacol Sci 31(3):108–114

    Article  CAS  PubMed  Google Scholar 

  8. Gochfeld M (2007) Framework for gender differences in human and animal toxicology. Environ Res 104:4–21

    Article  CAS  PubMed  Google Scholar 

  9. Beirle I, Meibohm B, Derendorf H (1999) Gender Differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther 37:529–547

    Google Scholar 

  10. Wang J, Huanf Y (2007) Pharmocogenomics of Sex Difference in Chemotherapeutic Toxicity. Curr Drug Discov Technol 4:59–68

    Article  CAS  PubMed  Google Scholar 

  11. Franconi F (2007) Brunelleschi, Stardo L, Cuomo V. Gender differences in drug responses. Pharmacol Res 55:81–95

    Article  CAS  PubMed  Google Scholar 

  12. Langer T, Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O (2013) Understanding platinum-induced ototoxicity. Trends Pharmacol Sci 1059:1–12

    Google Scholar 

  13. Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J of Cancer 40:2445–2451

    Article  CAS  Google Scholar 

  14. Yancey A, Haris MS, Egbelakin A et al (2012) Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients. Pediatr Blood Cancer 9:144–148

    Article  Google Scholar 

  15. Coradini PP, Cigana L, Selistre SG, Rosito LS, Brunetto AL (2007) Ototoxicity from cisplatin therapy in childhood cancer. J Pediatr Hematol Oncol 29(6):355–360

    Article  CAS  PubMed  Google Scholar 

  16. Olgun Y (2013) Cisplatin ototoxicity: where we are? Int Adv Otol 9(3):395–408

    Google Scholar 

  17. Wei Q et al (2005) Differential gender differences in ischemic and nephrotoxic acute renal failure. Am J Nephrol 25:491–499

    Article  CAS  PubMed  Google Scholar 

  18. Lu Y, Kawashima A, Horii I, Zhong L (2005) Cisplatin induced cytotoxicity in BSO-exposed renal proximal tubular epithelial cells: sex, age and species. Ren Fail 27(5):629–633

    Article  CAS  PubMed  Google Scholar 

  19. Pezeshki Z, Nematbakhsh M, Ashrafi F (2013) Evidence against protective role of sex hormone estrogen in cisplatin-induced nephrotoxicity in ovarectomized rat model. Toxicol Int 20(1):43–47

    Article  PubMed Central  PubMed  Google Scholar 

  20. Stakisaitis D, Dudeniene G, Jankūnas RJ, Grazeliene G, Didziapetriene J, Pundziene B (2010) Cisplatin increases urinary sodium excretion in rats: gender-related differences. Medicina (Kaunas) 46(1):45–50

    Google Scholar 

  21. Shabani M, Larizadeh MH, Parsania S, Hajali V, Shojaei A (2012) Evaluation of destructive effects of exposure to cisplatin during developmental stage: no profound evidence for sex differences in impaired motor and memory performance. Int J Neurosci 8:439–448

    Article  Google Scholar 

  22. Im GJ, Chang JW, Choi J, Chae W, Ko EJ, Jung HH (2010) Protective effect of korean red gingsenf extract on cisplatin ototoxicity in HEI-OC1 auditory cells. Phytothrer Res 24:614–621

    CAS  Google Scholar 

  23. Riga MG, Chelis L, Kakolyris S et al (2004) Prevention of cisplatin ototoxicity using transtympanic N- acetylcysteine and lactate. Otol Neurootol 25:910–915

    Article  Google Scholar 

Download references

Acknowledgments

This study was financially supported by a grant from Dokuz Eylul University Research Foundation.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yüksel Olgun.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kirkim, G., Olgun, Y., Aktas, S. et al. Is there a gender-related susceptibility for cisplatin ototoxicity?. Eur Arch Otorhinolaryngol 272, 2755–2763 (2015). https://doi.org/10.1007/s00405-014-3283-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-014-3283-0

Keywords

Navigation